Neurana Pharmaceuticals Appoints Randall Kaye, M.D., Chief Medical Officer SAN DIEGO, Calif., November 7, 2019 – Neurana Pharmaceuticals, a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today announced that it has appointed...
Neurana Pharmaceuticals Announces First Patient Enrolled in the STAR Study Neurana Pharmaceuticals Announces First Patient Enrolled in the “STAR Study,” a Phase 2 Dose Ranging Study of Tolperisone in Acute Muscle Spasms of the Back SAN DIEGO, February 4th, 2019...
Recent Comments